These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9607205)

  • 21. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW; Gohel MD
    Carbohydr Res; 2012 Jan; 347(1):64-8. PubMed ID: 22119438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter-alpha-trypsin inhibitor and its related proteins in Syrian hamster urine and plasma.
    Yamamoto T; Yamamoto K; Sinohara H
    J Biochem; 1996 Jul; 120(1):145-52. PubMed ID: 8864857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium oxalate crystal matrix extract: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro.
    Doyle IR; Marshall VR; Dawson CJ; Ryall RL
    Urol Res; 1995; 23(1):53-62. PubMed ID: 7618236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is citrate an inhibitor of calcium oxalate crystal growth in high concentrations of urine?
    Bek-Jensen H; Fornander AM; Nilsson MA; Tiselius HG
    Urol Res; 1996; 24(2):67-71. PubMed ID: 8740974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
    Grover PK; Moritz RL; Simpson RJ; Ryall RL
    Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.
    Wesson JA; Worcester EM; Wiessner JH; Mandel NS; Kleinman JG
    Kidney Int; 1998 Apr; 53(4):952-7. PubMed ID: 9551403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wu-Ling-San formula inhibits the crystallization of calcium oxalate in vitro.
    Chen YC; Ho CY; Chen LD; Hsu SF; Chen WC
    Am J Chin Med; 2007; 35(3):533-41. PubMed ID: 17597511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
    Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
    Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.
    Evan AP; Bledsoe S; Worcester EM; Coe FL; Lingeman JE; Bergsland KJ
    Kidney Int; 2007 Dec; 72(12):1503-11. PubMed ID: 17898697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells.
    Grover PK; Thurgood LA; Fleming DE; van Bronswijk W; Wang T; Ryall RL
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F355-61. PubMed ID: 18077596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.
    Chutipongtanate S; Nakagawa Y; Sritippayawan S; Pittayamateekul J; Parichatikanond P; Westley BR; May FE; Malasit P; Thongboonkerd V
    J Clin Invest; 2005 Dec; 115(12):3613-22. PubMed ID: 16308573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney.
    Atmani F; Glenton PA; Khan SR
    Urol Res; 1999; 27(1):63-7. PubMed ID: 10092155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.
    Hoyer JR; Asplin JR; Otvos L
    Kidney Int; 2001 Jul; 60(1):77-82. PubMed ID: 11422738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.
    Worcester EM; Sebastian JL; Hiatt JG; Beshensky AM; Sadowski JA
    Calcif Tissue Int; 1993 Oct; 53(4):242-8. PubMed ID: 8275352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The direct inhibitory effects of Lactobacillus acidophilus, a commensal urinary bacterium, on calcium oxalate stone development.
    Noonin C; Putpim A; Thongboonkerd V
    Microbiome; 2024 Sep; 12(1):175. PubMed ID: 39289694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.